This PROFITABLE Cancer Stock Has 10x Potential

Novocure stock is a profitable medical device company that has been a home-run stock for early investors. But is novocure stock a buy? In this nvcr stock analysis video, Brian Feroldi and Brian Stoffel take nvcr stock through their investing frameworks to find out.

Want to follow our portfolios on Stockcard:

Use promo code "antifragile" for 10% off!

◾Brian Feroldi's Quality Checklist portfolio:
◾Brian Stoffel's Anti-Fragile portfolio:
◾Brian Feroldi's Anti-Portfolio:
◾Brian Stoffel's Fragile Portfolio:

Комментариев нет.